1,3-indandione has been researched along with Insulin Resistance in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aftab, MF; Bano, B; Khan, G; Khan, KM; Murtaza, M; Rehman, MH; Siddiqui, S; Waraich, RS | 1 |
1 other study(ies) available for 1,3-indandione and Insulin Resistance
Article | Year |
---|---|
A new indanedione derivative alleviates symptoms of diabetes by modulating RAGE-NF-kappaB pathway in db/db mice.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Cell Survival; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression Regulation; Glucose; Glycation End Products, Advanced; Hep G2 Cells; Hepatocytes; Humans; Indans; Insulin Resistance; Mice; Mice, Inbred C57BL; NF-kappa B; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Signal Transduction | 2018 |